Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Bio Path Holdings buy shadow

Start price
€2.80
04.12.20 / 50%
Target price
-
04.12.21
Performance (%)
-81.43%
End price
€0.52
05.12.21
Summary
This prediction ended on 05.12.21 with a price of €0.52. Massive losses of -81.43% were the result for the BUY prediction by shadow. shadow has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Bio Path Holdings - - - -
iShares Core DAX® 1.883% 5.122% 21.667% 22.437%
iShares Nasdaq 100 0.125% 2.574% 45.951% 55.507%
iShares Nikkei 225® -0.201% 4.341% 28.806% 9.945%
iShares S&P 500 0.728% 4.141% 34.630% 50.086%

According to shadow what are the pros and cons of Bio Path Holdings for the foreseeable future?

Pros
positive Cash Flow expected
Capable Management
Differentiated customer and product portfolio
Future proof or reliable business model
Cons
Probably not worthwhile Investment
Revenue decline/stagnation expected
Lower EBIT Margin than peer group
High valuation
EBIT decline/stagnation expected
Low dividend yield expected
Bad rating
Little Investments for future growth
Risky balance sheet
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
Bad culture
Little innovation
Few uniques
Growths slower than the competition
Sustainability is little important
high free float
Higher risks for its business
Below average Marketposition
Significant cyclical dependencies
Little known brand

Comments by shadow for this prediction

In the thread Bio Path Holdings diskutieren

Buy Bio Path Holdings

In the thread Trading Bio Path Holdings
Prediction Buy
Perf. (%) -81.43%
Target price
Change
Ends at 04.12.21

Die von shadow gewählte maximale Laufzeit wurde überschritten